Bringing the benefits of multiple assays into one
Helix’s Exome+® assay has been carefully optimized to provide the benefits of lcWGS, whole exome sequencing, microarrays, and targeted panels — all in one assay.
Targeted Panels
Panels are often used in clinical settings because they’re low cost and provide high quality coverage of specific, pre-defined genomic regions of interest. While useful in certain settings, such assays are limited by their narrow focus.
With ≥ 99.5% call rate across ~600 genes relevant to many disease states, the Exome+ assay enables you to run multiple panel-grade analyses with a single sample.
Whole Exome Sequencing
Panels are often used in clinical settings because they’re low cost and provide high quality coverage of specific, pre-defined genomic regions of interest. While useful in certain settings, such assays are limited by their narrow focus.
With ≥ 99.5% call rate across ~600 genes relevant to many disease states, the Exome+ assay enables you to run multiple panel-grade analyses with a single sample.
lcWGS and Microarrays
Panels are often used in clinical settings because they’re low cost and provide high quality coverage of specific, pre-defined genomic regions of interest. While useful in certain settings, such assays are limited by their narrow focus.
With ≥ 99.5% call rate across ~600 genes relevant to many disease states, the Exome+ assay enables you to run multiple panel-grade analyses with a single sample.
A future proofed assay
There are several advantages to running panels in the presence of a whole exome, including flexible test design, flexible re-testing, and increased functionality.